0000899243-18-006980.txt : 20180309 0000899243-18-006980.hdr.sgml : 20180309 20180309180050 ACCESSION NUMBER: 0000899243-18-006980 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180307 FILED AS OF DATE: 20180309 DATE AS OF CHANGE: 20180309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hughes Thomas E. CENTRAL INDEX KEY: 0001611048 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 18681369 MAIL ADDRESS: STREET 1: C/O ZAFGEN, INC. STREET 2: ONE BROADWAY, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZAFGEN, INC. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 175 PORTLAND STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02114 BUSINESS PHONE: 617-622-4003 MAIL ADDRESS: STREET 1: 175 PORTLAND STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02114 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-07 0 0001374690 ZAFGEN, INC. ZFGN 0001611048 Hughes Thomas E. C/O ZAFGEN, INC. 175 PORTLAND STREET, 4TH FLOOR BOSTON MA 02114 1 1 0 0 See Remarks Common Stock 2018-03-07 4 S 0 5000 10.00 D 157247 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Includes 4,876 shares acquired under the employee stock purchase plan purchased in July 2017 and in January 2018. President and Chief Scientific Officer /s/ Laurie Burlingame (Attorney-In-Fact) 2018-03-09